Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents

Clinical and Developmental Immunology

Volumn 2010, Issue , 2010, Pages

  Baldo, Vincenzo ^a   Baldovin, Tatjana ^a   Pellegrini, Michele ^b   Angiolelli, Gabriele ^c   Majori, Silvia ^d   Floreani, Annarosa ^a   Busana, Marta Cecilia ^a   Bertoncello, Chiara ^a   Trivello, Renzo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^c Local Health Unit n13   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; VIROSOME VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN;

AGED; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CASE REPORT; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GERIATRIC PATIENT; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS STRAIN; BLOOD; COMPARATIVE STUDY; GENETICS; HEMAGGLUTINATION INHIBITION TEST; HUMORAL IMMUNITY; IMMUNOLOGY; ITALY; ORTHOMYXOVIRUS; PATHOGENICITY; PHYLOGENY; SPECIES DIFFERENCE; VACCINATION;

AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNITY, HUMORAL; INFLUENZA VACCINES; INFLUENZA, HUMAN; ITALY; MALE; NURSING HOMES; ORTHOMYXOVIRIDAE; PHYLOGENY; SPECIES SPECIFICITY; VACCINATION;

EID: 77951523994     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2010/517198     Document Type: Article

References (32)

1. Thompson W. W., Shay D. K., Weintraub E., Mortality associated with influenza and respiratory syncytial virus in the United States Journal of the American Medical Association 2003 289 2 179 186 (Pubitemid 36068705)
2. Ferrucci L., Guralnik J. M., Pahor M., Corti M. C., Havlik R. J., Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled Journal of the American Medical Association 1997 277 9 728 734 (Pubitemid 27106225)
3. McElhaney J. E., The unmet need in the elderly: designing new influenza vaccines for older adults Vaccine 2005 23 supplement 1 S10 S25
4. Van Hoecke Ch., Prikazsky V., Uto I., Menschikowski C., Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients Gerontology 1996 42 4 190 198 (Pubitemid 26229374)
5. Sprenger M. J. W., Mulder P. G. H., Beyer W. E. P., Van Strik R., Masurel N., Impact of influenza on mortality in relation to age and underlying disease, 19671989 International Journal of Epidemiology 1993 22 2 334 340 (Pubitemid 23129339)
6. Baldo V., Menegon T., Bonello C., Floreani A., Trivello R., Comparison of three different influenza vaccines in institutionalised elderly Vaccine 2001 19 25-26 3472 3475 (Pubitemid 32710298)
7. Reichert T. A., Simonsen L., Sharma A., Pardo S. A., Fedson D. S., Miller M. A., Influenza and the winter increase in mortality in the United States, 19591999 American Journal of Epidemiology 2004 160 5 492 502 (Pubitemid 39166983)
8. Thompson W. W., Shay D. K., Weintraub E., Influenza-associated hospitalizations in the United States Journal of the American Medical Association 2004 292 11 1333 1340 (Pubitemid 39223224)
9. WHO 2003: Fact sheet no. 211., July 2009, http://www.who.int/mediacentre/ factsheets/fs211/en/Web
10. Nichol K. L., The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines Vaccine 2003 21 16 1769 1775
11. Herndler-Brandstetter D., Schwaiger S., Veel E., CD25-expressing CD8 + T cells are potent memory cells in old age Journal of Immunology 2005 175 3 1566 1574 (Pubitemid 41023058)
12. Lazuardi L., Jenewein B., Wolf A. M., Pfister G., Tzankov A., Grubeck-Loebenstein B., Age-related loss of naive T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes Immunology 2005 114 1 37 43 (Pubitemid 40030291)
13. Weinberger B., Herndler-Brandstetter D., Schwanninger A., Weiskopf D., Grubeck-Loebenstein B., Biology of immune responses to vaccines in elderly persons Clinical Infectious Diseases 2008 46 7 1078 1084 (Pubitemid 351589876)
14. Cox N. J., Subbarao K., Global epidemiology of influenza: past and present Annual Review of Medicine 2000 51 407 421 (Pubitemid 30216046)
15. Monto A. S., Epidemiology and virology of influenza illness American Journal of Managed Care 2000 6 5 S255 S264
16. Nordin J., Mullooly J., Poblete S., Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans Journal of Infectious Diseases 2001 184 6 665 670 (Pubitemid 32826416)
17. Treanor J., Influenza caccineoutmaneuvering antigenic shift and drift New England Journal of Medicine 2004 350 3 218 220 (Pubitemid 38067634)
18. de Jong J. C., Beyer W. E. P., Palache A. M., Rimmelzwaan G. F., Osterhaus A. D. M. E., Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly Journal of Medical Virology 2000 61 1 94 99
19. Ansaldi F., Bacilieri S., Banfi F., Neutralizing and hemagglutination- inhibiting activities of antibodies elicited by the 2004-2005 influenza vaccine against drifted viruses Clinical and Vaccine Immunology 2006 13 1 162 164
20. Giudice G. D., Hilbert A. K., Bugarini R., An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine Vaccine 2006 24 16 3063 3065
21. Kojimahara N., Maeda A., Kase T., Yamaguchi N., Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine Vaccine 2006 24 33-34 5966 5969 (Pubitemid 44080364)
22. Ansaldi F., Bacilieri S., Durando P., Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses Vaccine 2008 26 12 1525 1529
23. Menegon T., Baldo V., Bonello C., Dalla Costa D., Di Tommaso A., Trivello R., Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population European Journal of Epidemiology 1999 15 6 573 576 (Pubitemid 29400033)
24. Kanegae Y., Sugita S., Endo A., Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season Journal of Virology 1990 64 6 2860 2865 (Pubitemid 20171276)
25. Tamura K., Dudley J., Nei M., Kumar S., MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0 Molecular Biology and Evolution 2007 24 8 1596 1599 (Pubitemid 47236692)
26. Beyer W. E. P., Palache A. M., Luchters G., Nauta J., Osterhaus A. D. M. E., Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Research 2004 103 1-2 125 132 (Pubitemid 38649071)
27. Cate T. R., Clinical manifestations and consequences of influenza American Journal of Medicine 1987 82 6 15 19
28. Nauta J. J. P., Beyer W. E. P., Osterhaus A. D. M. E., On the relationship between mean antibody level, seroprotection and clinical protection from influenza Biologicals 2009 37 4 216 221
29. Monto A. S., Kendal A. P., Effect of neuraminidase antibody on Hong Kong influenza The Lancet 1973 1 7804 623 625
30. Forrest B. D., Pride M. W., Dunning A. J., Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children Clinical and Vaccine Immunology 2008 15 7 1042 1053
31. Kilbourne E. D., Plotkin A., Mortimer E. A., Inactivated influenza vaccines Vaccines 1994 Philadelphia, Pa, USA Saunders 565 581
32. Clements M. L., Stephens I., New and improved vaccines against influenza New Generation Vaccines 1997 2nd New York, NY, USA Marcel Dekker 545 570